Parexel has confirmed that Panthera Biopartners has become the first UK public or commercial clinical trial organisation to become part of the Parexel Site Alliance Vaccine Network. Parexel’s Site Alliance Vaccine Network is a global network of high performing clinical trial sites which fosters long-term collaborative relationships with select research organizations across the globe to

Since announcing that it reopened its oncology clinical trials division earlier this year, Panthera Biopartners has been selected by two of the world’s largest pharma companies to run oncology trials at sites across the UK. Panthera previously had to close its Oncology division as the sites were located inside the four Rutherford Specialist Cancer clinics,

Panthera’s SMO model delivers market-leading patient recruitment for vaccine trials In the post-COVID-19 period, the UK has emerged as a world leader in vaccine trials, but data from two case studies shows that Panthera is not only outperforming global sites, but also competitor sites across the UK. In a recent COVID-19 booster healthy volunteer vaccine trial, Panthera’s